Birge Bargmann

Keine laufenden Positionen mehr

62 Jahre

Health Technology

Consumer Services

Profil

Birge Bargmann is the founder of Proteo, Inc., which was founded in 1992.
At Proteo, Inc., she held the titles of President, Chief Executive Officer, CFO & Director from 2005 to 2018.
She also worked at the University of Kiel as Head-Laboratory Proteolysis from 1987 to 2005.
Additionally, she was the Chief Executive & Financial Officer at tiakis BIOTECH AG from 2002 to 2012.

Ehemalige bekannte Positionen von Birge Bargmann

Unternehmen	Position	Ende
PROTEO, INC.	Vorstandsvorsitzender	15.11.2018
University of Kiel	Corporate Officer/Principal	01.01.2005
tiakis BIOTECH AG tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow.	Vorstandsvorsitzender	-

Sehen Sie sich die Erfahrung von Birge Bargmann im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Birge Bargmann im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Proteo, Inc. Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA.	Health Technology
tiakis BIOTECH AG tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow.	Health Technology